Clinical Trial Update: Use of Omega-3 Fatty Acids (Fish Oil) in Patients With Chronic Hepatitis C Infection [NA]

View source ↗

Summary

A clinical trial evaluating omega-3 fatty acids (fish oil) in patients with chronic hepatitis C has been withdrawn; no results are reported.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatitis C

Drugs mentioned

• Omega-3 fatty acids (fish oil) (omega-3 fatty acids)

Snippet

Sponsor: University of Missouri, Kansas City | Conditions: Hepatitis C | NA | Status: WITHDRAWN